Skip to content

Omeros OMER Change in Inventories

Change in Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$431M+195%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$1.32M+598%
Opko Health logo
Opko HealthOPK
-$191K-104%
Eli Lilly logo
Eli LillyLLY
$1.17B+86.3%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's change in inventories?
Omeros (OMER) reported change in inventories of $183K in Q1 2026.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.